Foundation Medicine Stock Price, News & Analysis (NASDAQ:FMI) Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Foundation Medicine Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume621,352 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Foundation Medicine, Inc provides various molecular information products in the United States. The company's molecular information platform includes proprietary methods and algorithms to analyze specimens across various types of cancer, as well as for incorporating that information into clinical care; and offers genomic insights about each patient's individual cancer, enabling physicians to optimize treatments in clinical practice and biopharmaceutical companies to develop targeted therapies and immunotherapies. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Medical laboratories Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:FMI Previous Symbol CUSIPN/A CIK1488613 Webhttp://www.foundationmedicine.com/ Phone617-418-2200Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableOptionable Receive FMI News and Ratings via Email Sign-up to receive the latest news and ratings for FMI and its competitors with MarketBeat's FREE daily newsletter. Foundation Medicine (NASDAQ:FMI) Frequently Asked Questions What is Foundation Medicine's stock symbol? Foundation Medicine trades on the NASDAQ under the ticker symbol "FMI." How were Foundation Medicine's earnings last quarter? Foundation Medicine Inc (NASDAQ:FMI) posted its quarterly earnings results on Wednesday, May, 2nd. The company reported ($1.02) earnings per share for the quarter, beating the consensus estimate of ($1.10) by $0.08. The firm earned $52.84 million during the quarter, compared to analysts' expectations of $44.99 million. The business's quarterly revenue was up 100.7% on a year-over-year basis. During the same period last year, the company earned ($1.31) EPS. View Foundation Medicine's Earnings History. Has Foundation Medicine been receiving favorable news coverage? Media stories about FMI stock have trended neutral recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Foundation Medicine earned a daily sentiment score of 0.2 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Foundation Medicine. Who are some of Foundation Medicine's key competitors? Some companies that are related to Foundation Medicine include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Guardant Health (GH), ELEKTA AB/ADR (EKTAY), Natera (NTRA), Genomic Health (GHDX), InVitae (NVTA), Veracyte (VCYT), CareDx (CDNA), RadNet (RDNT), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Celcuity (CELC) and Enzo Biochem (ENZ). What other stocks do shareholders of Foundation Medicine own? Based on aggregate information from My MarketBeat watchlists, some companies that other Foundation Medicine investors own include Corbus Pharmaceuticals (CRBP), Visa (V), Gilead Sciences (GILD), HP (HPQ), Celgene (CELG), Myriad Genetics (MYGN), QUALCOMM (QCOM), Viveve Medical (VIVE), EXACT Sciences (EXAS) and GW Pharmaceuticals PLC- (GWPH). Who are Foundation Medicine's key executives? Foundation Medicine's management team includes the folowing people: Mr. Troy Cox, CEO, Pres & Director (Age 54)Mr. Michael Doherty, Head of Product Devel. (Age 59)Mr. Jason Ryan, Chief Financial Officer (Age 44)Mr. Konstantin Fiedler, Chief Operating Officer (Age 52)Mr. Tom Godden, Chief Information Officer What is Foundation Medicine's official website? The official website for Foundation Medicine is http://www.foundationmedicine.com/. How can I contact Foundation Medicine? Foundation Medicine's mailing address is 150 Second Street, Cambridge MA, 02141. The company can be reached via phone at 617-418-2200 or via email at [email protected] MarketBeat Community Rating for Foundation Medicine (NASDAQ FMI)Community Ranking: 1.8 out of 5 ()Outperform Votes: 210 (Vote Outperform)Underperform Votes: 380 (Vote Underperform)Total Votes: 590MarketBeat's community ratings are surveys of what our community members think about Foundation Medicine and other stocks. Vote "Outperform" if you believe FMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FMI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/18/2019 by MarketBeat.com StaffFeatured Article: Should I follow buy, hold and sell recommendations?